Pfizer has filed a lawsuit against Metsera and Novo Nordisk, saying Metsera breached its merger agreement obligations.

A trial funded by the Labour Government will ensure obese Scots have free access to Wegovy medication that can cost over £100 ...

Pfizer must convince Delaware courts that Novo, already dominant in GLP-1 treatments with Wegovy and Ozempic ... The post ...

Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication ...

Here are some companies that have moved to cut jobs recently. General Motors moved to lay off about 1,700 workers across manufacturing sites in Michigan and Ohio on Wednesday, as the auto giant ...

Email: [email protected] Jeremy Clarkson, yet again, appears to be having problems with his trousers falling down after making the switch to weight-loss drugs. The Grand Tour presenter, 65, underwent ...

It's a tough time for the job market. Amid wider economic uncertainty, some analysts have said that businesses are at a ...

New Scripps Research trial will explore the effects of Lilly’s GLP-1 drug on reducing the symptoms of the debilitating disease.

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and fueling a bidding war over another drugmaker.

Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based Pfizer said Friday after markets closed that it was suing Metsera and a ...

Up to 5,000 people in Scotland will take the injections as part of a multi-million pound study being led by Glasgow ...

With a new generation of weight-loss drugs entering Indian markets, spelling hope for many, The Indian Express tracks the ...